UBE2B and ovarian carcinoma: Consequently, the activation of UBE2B leads to the enhancement of stem cell gene expression and promotion of malignant characteristics in ovarian cells, thereby contributing to chemotherapy resistance, metastasis, and recurrence in patients with ovarian cancer (32).